Related Experiment Videos
Testosterone replacement therapy in male hypogonadism.
1Institute of Reproductive Medicine, University of Münster, Münster, Germany.
Journal of Endocrinological Investigation
|August 9, 2003
Summary
Testosterone replacement therapy is beneficial for men with hypogonadism, with newer gels and long-acting injections offering improved options. Careful monitoring of hematocrit, liver function, lipids, and PSA is essential for all patients.
Area of Science:
- Endocrinology
- Andrology
- Men's Health
Background:
- Testosterone, secreted in a circadian rhythm, is vital for male sexual characteristics, muscle mass, bone density, and cognitive function.
- Overt hypogonadism in men can be effectively treated with testosterone replacement therapy (TRT).
- Natural testosterone formulations are preferred over modified molecules for TRT.
Purpose of the Study:
- To review current experiences with various testosterone formulations for treating male hypogonadism.
- To highlight recent advancements in testosterone replacement therapy.
Main Methods:
- Review of current literature and clinical experience with testosterone replacement therapy.
- Discussion of available testosterone preparations: oral, intramuscular, subcutaneous, and transdermal (gels).
Main Results:
- Testosterone gels offer dosing flexibility, minimal skin irritation, and good patient compliance.
- Longer-acting intramuscular preparations provide stable testosterone levels and extended injection intervals.
- All patients on TRT require monitoring for hematocrit, liver function, lipid profiles, and prostate-specific antigen (PSA).
Conclusions:
- Testosterone replacement therapy is a valuable treatment for male hypogonadism.
- Recent innovations in TRT formulations enhance patient compliance and therapeutic outcomes.
- Close patient monitoring is crucial during testosterone therapy to manage potential side effects.